140 related articles for article (PubMed ID: 16054748)
1. Innovations in serum and urine markers in prostate cancer current European research in the P-Mark project.
van Gils MP; Stenman UH; Schalken JA; Schröder FH; Luider TM; Lilja H; Bjartell A; Hamdy FC; Pettersson KS; Bischoff R; Takalo H; Nilsson O; Mulders PF; Bangma CH
Eur Urol; 2005 Dec; 48(6):1031-41. PubMed ID: 16054748
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of serum markers for prostate cancer.
Stenman UH; Abrahamsson PA; Aus G; Lilja H; Bangma C; Hamdy FC; Boccon-Gibod L; Ekman P
Scand J Urol Nephrol Suppl; 2005 May; (216):64-81. PubMed ID: 16019759
[TBL] [Abstract][Full Text] [Related]
3. Prostate-specific antigen kinetics in localized and advanced prostate cancer.
Fitzpatrick JM; Banu E; Oudard S
BJU Int; 2009 Mar; 103(5):578-87. PubMed ID: 19210674
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer and prostate-specific antigen (PSA) screening in Austria.
Vutuc C; Schernhammer ES; Haidinger G; Waldhör T
Wien Klin Wochenschr; 2005 Jul; 117(13-14):457-61. PubMed ID: 16091872
[TBL] [Abstract][Full Text] [Related]
5. Serum human glandular kallikrein 2 (hK2) for distinguishing stage and grade of prostate cancer.
Stephan C; Jung K; Nakamura T; Yousef GM; Kristiansen G; Diamandis EP
Int J Urol; 2006 Mar; 13(3):238-43. PubMed ID: 16643616
[TBL] [Abstract][Full Text] [Related]
6. [PSA related screening of prostate cancer. Panic or improvement?].
Fornara P; Jurczok A
Aktuelle Urol; 2004 Feb; 35(1):43-8. PubMed ID: 14997414
[TBL] [Abstract][Full Text] [Related]
7. hK2 and free PSA, a prognostic combination in predicting minimal prostate cancer in screen-detected men within the PSA range 4-10 ng/ml.
Raaijmakers R; de Vries SH; Blijenberg BG; Wildhagen MF; Postma R; Bangma CH; Darte C; Schröder FH
Eur Urol; 2007 Nov; 52(5):1358-64. PubMed ID: 17499425
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of serum and urinary myeloid related protein-14 as a marker for early detection of prostate cancer.
Müller H; Haug U; Rothenbacher D; Stegmaier C; Brenner H
J Urol; 2008 Oct; 180(4):1309-12; discussion 1312-3. PubMed ID: 18707695
[TBL] [Abstract][Full Text] [Related]
9. Prostate specific antigen: an updated review.
So A; Goldenberg L; Gleave ME
Can J Urol; 2003 Dec; 10(6):2040-50. PubMed ID: 14704108
[TBL] [Abstract][Full Text] [Related]
10. Early diagnosis of prostate cancer: the continuing debate on the impact on mortality.
Höltl W; Lunglmayr G
Wien Klin Wochenschr; 2005 Jul; 117(13-14):440-1. PubMed ID: 16091868
[No Abstract] [Full Text] [Related]
11. Beyond prostate-specific antigen: alternate serum markers.
Ramírez ML; Nelson EC; Evans CP
Prostate Cancer Prostatic Dis; 2008; 11(3):216-29. PubMed ID: 18227856
[TBL] [Abstract][Full Text] [Related]
12. PSA and other tissue kallikreins for prostate cancer detection.
Stephan C; Jung K; Lein M; Diamandis EP
Eur J Cancer; 2007 Sep; 43(13):1918-26. PubMed ID: 17689069
[TBL] [Abstract][Full Text] [Related]
13. [Markers for diagnosis, prediction and prognosis of prostate cancer].
Taskén KA; Angelsen A; Svindland A; Eide T; Berge V; Wahlquist R; Karlsen S
Tidsskr Nor Laegeforen; 2005 Dec; 125(23):3279-82. PubMed ID: 16327854
[TBL] [Abstract][Full Text] [Related]
14. New circulating biomarkers for prostate cancer.
Bensalah K; Lotan Y; Karam JA; Shariat SF
Prostate Cancer Prostatic Dis; 2008; 11(2):112-20. PubMed ID: 17998918
[TBL] [Abstract][Full Text] [Related]
15. Prostate-specific antigen doubling time as a prognostic marker in prostate cancer.
Eastham JA
Nat Clin Pract Urol; 2005 Oct; 2(10):482-91. PubMed ID: 16474622
[TBL] [Abstract][Full Text] [Related]
16. Are multiple markers the future of prostate cancer diagnostics?
Mikolajczyk SD; Song Y; Wong JR; Matson RS; Rittenhouse HG
Clin Biochem; 2004 Jul; 37(7):519-28. PubMed ID: 15234233
[TBL] [Abstract][Full Text] [Related]
17. Screening for prostate cancer in 2008 II: the importance of molecular subforms of prostate-specific antigen and tissue kallikreins.
Jansen FH; Roobol M; Jenster G; Schröder FH; Bangma CH
Eur Urol; 2009 Mar; 55(3):563-74. PubMed ID: 19058905
[TBL] [Abstract][Full Text] [Related]
18. [The search for better markers for prostate cancer than prostate-specific antigen].
Schenk-Braat EA; Bangma CH
Ned Tijdschr Geneeskd; 2006 Jun; 150(23):1286-90. PubMed ID: 16821452
[TBL] [Abstract][Full Text] [Related]
19. Blood biomarkers for prostate cancer detection and prognosis.
Shariat SF; Karam JA; Roehrborn CG
Future Oncol; 2007 Aug; 3(4):449-61. PubMed ID: 17661720
[TBL] [Abstract][Full Text] [Related]
20. Lack of progress in early diagnosis of bladder cancer.
Araki M; Nieder AM; Manoharan M; Yang Y; Soloway MS
Urology; 2007 Feb; 69(2):270-4. PubMed ID: 17320662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
